相关实验视频
Updated: Jan 10, 2026

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.9K
血小板转录组调节失调在利维体连续体中是否反映神经功能障碍?
Laura Arnaldo1,2, Jorge Mena1, David Adamuz1,3
1Department of Neuroscience, Research Institute Germans Trias i Pujol, 08916 Badalona, Spain.
International journal of molecular sciences
|November 27, 2025
概括
血小板在神经退行性疾病中显示出明显的RNA特征,例如勒维体痴呆症 (DLB) 和异常REM睡眠行为障碍 (IRBD). 这项研究表明,血小板是对α-synucleinopathies的可访问生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 血液学 血液学 血液学
背景情况:
- 血小板是多功能细胞,参与血液静止,免疫调节,炎症和神经退行.
- 阿尔法同核蛋白病变,包括患有勒维体 (DLB) 的痴呆症和帕金森病 (PD),是复杂的神经退行性疾病.
- 异常性REM睡眠行为障碍 (IRBD) 是α-synucleinopathies的早期迹象.
研究的目的:
- 调查来自IRBD,DLB,PD,阿尔茨海默病 (AD) 和健康对照 (CTRL) 患者血小板中的疾病特异性转录组特征.
- 探索血小板RNA资料在α-synucleinopathies的发病和进展中的作用.
主要方法:
- 从患者队列和健康对照中对血小板进行RNA测序 (RNA-Seq) 分析.
- 差异表达分析 (DEA) 用于识别转录组变化.
- 分析RNA类分布,包括信使RNA (mRNA) 和长非编码RNA (lncRNA).
主要成果:
- 来自DLB患者的血小板显示了lncRNAs的比例降低,表明潜在的RNA调节障碍.
- IRBD血小板表现出最多的疾病特异性lncRNAs,其中许多与Y结合,与alpha-synucleinopathies中男性占主导地位相关.
- 在IRBD和DLB中观察到广泛的转录基因重塑,影响RNA处理,细胞骨组织和血小板激活通路.
- PD和AD显示出最小的转录基因变化,可能是由于疾病异质性.
结论:
- 血小板转录组形状提供了对α-synucleinopathies的疾病特异性分子变化的洞察.
- 在DLB中血小板激活和信号的逐渐损害可能反映神经元功能障碍.
- 血小板作为可访问的生物标志物用于神经退行性疾病的早期和疾病阶段特定的分子变化.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.帕金森病是帕金森氏症的一种疾病.有关RNA测序的RNA测序患有利维体痴呆症的痴呆症不同的基因表达方式异常发病的REM睡眠行为障碍血小板转录组 血小板转录组更多相关视频
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
7.7K
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
1.3K
相关概念视频
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K